Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 13 of 13 entries
Sorted by: Best Match Show Resources per page
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.

Therapeutic advances in medical oncology

Vary A, Lebellec L, Di Fiore F, Penel N, Cheymol C, Rad E, El Hajbi F, Lièvre A, Edeline J, Bimbai AM, Le Deley MC, Turpin A.
PMID: 34349842
Ther Adv Med Oncol. 2021 Jul 16;13:17588359211029825. doi: 10.1177/17588359211029825. eCollection 2021.

BACKGROUND: Most patients with advanced pancreatic adenocarcinoma (PA) treated with FOLFIRINOX experience adverse events requiring dose reduction. We aimed to assess the association between relative dose intensity (RDI) and disease control in a European setting.METHODS: We retrospectively included patients...

Cite
Vary A, Lebellec L, Di Fiore F, et al. FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma. Ther Adv Med Oncol. 2021;13:17588359211029825doi: 10.1177/17588359211029825.
Vary, A., Lebellec, L., Di Fiore, F., Penel, N., Cheymol, C., Rad, E., El Hajbi, F., Lièvre, A., Edeline, J., Bimbai, A. M., Le Deley, M. C., & Turpin, A. (2021). FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma. Therapeutic advances in medical oncology, 1317588359211029825. https://doi.org/10.1177/17588359211029825
Vary, Antonin, et al. "FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma." Therapeutic advances in medical oncology vol. 13 (2021): 17588359211029825. doi: https://doi.org/10.1177/17588359211029825
Vary A, Lebellec L, Di Fiore F, Penel N, Cheymol C, Rad E, El Hajbi F, Lièvre A, Edeline J, Bimbai AM, Le Deley MC, Turpin A. FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma. Ther Adv Med Oncol. 2021 Jul 16;13:17588359211029825. doi: 10.1177/17588359211029825. eCollection 2021. PMID: 34349842; PMCID: PMC8287268.
Copy Download .nbib Format: NLM
Showing 13 to 13 of 13 entries